Changeflow GovPing Healthcare & Life Sciences Chugai Seiyaku Aggrecan Binding Domain Polypept...
Routine Notice Added Final

Chugai Seiyaku Aggrecan Binding Domain Polypeptide Patent

Favicon for changeflow.com EPO Patent Bulletin - Peptides (C07K)
Published
Detected
Email

Summary

The European Patent Office published patent application EP3807312A1, filed by Chugai Seiyaku Kabushiki Kaisha, covering a polypeptide comprising an aggrecan binding domain and a carrying moiety. This publication grants Chugai Seiyaku intellectual property protection in all designated Contracting States of the European Patent Convention. The invention relates to therapeutic applications for osteoarthritis and related conditions, classified under IPC codes including C07K 16/18.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 46 changes logged to date.

What changed

The EPO published EP3807312A1, a patent application by Chugai Seiyaku Kabushiki Kaisha for a novel polypeptide comprising an aggrecan binding domain and carrying moiety. The application covers therapeutic uses for musculoskeletal conditions and provides IP protection across all designated European Patent Convention states.

Pharmaceutical R&D teams working in musculoskeletal or cartilage-related therapeutics should conduct freedom-to-operate analyses to determine whether this granted patent creates obstacles for their development programs.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

POLYPEPTIDE COMPRISING AGGRECAN BINDING DOMAIN AND CARRYING MOIETY

Publication EP3807312A1 Kind: A1 Apr 15, 2026

Applicants

CHUGAI SEIYAKU KABUSHIKI KAISHA

Inventors

KITAMURA, Hidetomo, HOSHINO, Maiko, SUN, Yang, KURAMOCHI, Taichi, TU, Wenjie, IGAWA, Tomoyuki, HIRONIWA, Naoka, NOGUCHI, Yuki

IPC Classifications

C07K 16/18 20060101AFI20220616BHEP A61K 39/395 20060101ALI20220616BHEP A61P 19/04 20060101ALI20220616BHEP C07K 19/00 20060101ALI20220616BHEP C12P 21/08 20060101ALI20220616BHEP C12N 15/62 20060101ALI20220616BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Notice
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Pharmaceutical companies Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent publication IP protection Drug development
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!